Healthcare
RavenQuest BioMed Inc.(RVVQF)
Live Price
Offline$0.00001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 โ Jun 18, 2026
- Market Cap
- โ
- Revenue Growth
- +1018.8%
- EPS Growth
- -230.0%
- Dividend Yield
- 0.0%
Coverage: 249 bars ยท Jun 23, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
RavenQuest BioMed Inc. (RVVQF) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +1018.8%, EPS growth of -230.0%, a dividend yield of 0.0%. What stands out right now is revenue +1018.8%, EPS -230.0%, free cash flow -830.2% with operating margin -1366.4% and ROIC -47.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines RVVQF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+1018.8% vs +7.6% peer median
Operating Margin
Below sector median
-1366.4% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2024 was reported on Oct 4, 2024, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +1018.8% and EPS is at -230.0%, with operating margin around -1366.4%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2024 Oct 4, 2024 | โ | +0.0% | +0.0% | +0.0% |
2024 Jul 3, 2024 | โ | +0.0% | +0.0% | +0.0% |
2024 Apr 3, 2024 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RVVQF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
RVVQF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for RVVQF and SPY.
Company Overview
RavenQuest BioMed Inc.
Other OTC
RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. The company operates in two segments, Consulting Business, and Cultivation and Sale of Medical Cannabis. It offers its products under the Lore Cannabis and Bloomera brand names. The company was formerly known as Ravencrest Resources Inc. and changed its name to RavenQuest BioMed Inc. in September 2017. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada.
- Leadership
- David Allen Cross
- IPO Date
- Mar 5, 2018
- Street Address
- 580 Hornby Street
- Mailing
- Vancouver, BC, V6E 2K3
- Region
- Vancouver, BC, CA
- Reporting Currency
- USD
- Investor Line
- 877-282-1586
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.0
- Price/Book
- 0.0
Growth
- Revenue
- +1018.8%
- EPS
- -230.0%
- Free Cash Flow
- -830.2%
Profitability
- Gross Margin
- 63.7%
- Operating Margin
- -1366.4%
- Net Margin
- -2423.9%
- ROE
- -203.4%
- ROIC
- -47.3%
Balance Sheet
- Debt/Equity
- 0.59
- Current Ratio
- 1.14
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.